Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Self-managed long-term low-molecular-weight heparin therapy: the balance of benefits and harms.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Self-managed long-term low-molecular-weight heparin therapy: the balance of benefits and harms.
Self-managed long-term low-molecular-weight heparin therapy: the balance of benefits and harms. Am J Med. 2007 Jan; 120(1):72-82.
View in:
PubMed
subject areas
Anticoagulants
Anticoagulants
Cause of Death
Cause of Death
Female
Female
Fibrinolytic Agents
Fibrinolytic Agents
Hemorrhage
Hemorrhage
Heparin, Low-Molecular-Weight
Heparin, Low-Molecular-Weight
Humans
Humans
Male
Male
Middle Aged
Middle Aged
Recurrence
Recurrence
Self Administration
Self Administration
Treatment Outcome
Treatment Outcome
Venous Thrombosis
Venous Thrombosis
Vitamin K
Vitamin K
Warfarin
Warfarin
authors with profiles
Gary E Raskob